# Iris and anterior chamber angle melanoma masquerading as benign melanocytic lesion

**Authors:** Mai-Linh N. Ton, Maria Del Valle Estopinal, Kapil Mishra

PMC · DOI: 10.1016/j.ajoc.2025.102353 · American Journal of Ophthalmology Case Reports · 2025-05-09

## TL;DR

This case study shows how combining clinical exams, lab tests, and genetic analysis helps distinguish between benign and malignant eye tumors.

## Contribution

The study emphasizes the importance of a multi-modal diagnostic approach for complex ocular melanocytic lesions.

## Key findings

- A benign conjunctival nevus was reclassified as iris melanoma with extrascleral extension through comprehensive testing.
- Immunohistochemistry confirmed melanocytic cell infiltration in multiple ocular structures.
- A GNA11 mutation was identified, supporting the uveal origin of the tumor.

## Abstract

Demonstrates the importance of integrating clinical findings, immunohistochemistry, and next-generation sequencing of somatic mutations in differentiating complex ocular melanocytic lesions. This study highlights distinct differences between benign conjunctival nevus, iris melanoma with extrascleral extension, and conjunctival melanoma with intraocular invasion.

A 62-year-old male presented with painless vision loss and multiple pigmented lesions on the ocular surface. Initial impression was a benign conjunctival nevus but concerning for melanoma due to secondary changes of vision loss and increased intraocular pressure. Further investigation revealed an iris melanoma involving the anterior chamber angle with extrascleral extension. Enucleation confirmed atypical melanocytic cells infiltrating the iris stroma, anterior chamber angle, sclera, and conjunctiva. Immunohistochemistry showed SRY-Box Transcription Factor 10 (SOX10) and melanoma antigen (Melan-A) positivity. Gene sequencing identified a Guanine nucleotide-binding protein, alpha-11 (GNA11) mutation, suggesting uveal origin.

Highlights the value of a comprehensive diagnostic approach in evaluating ocular melanocytic lesions. The progression from an initial impression of benign conjunctival nevus to the discovery of iris melanoma with extrascleral extension emphasizes the need for thorough investigation, especially when pathological changes such as increased intraocular pressure and vision loss occur.

## Linked entities

- **Genes:** GNA11 (G protein subunit alpha 11) [NCBI Gene 2767], SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663]
- **Diseases:** melanoma (MONDO:0005105), conjunctival nevus (MONDO:0006172)

## Full-text entities

- **Genes:** GNA11 (G protein subunit alpha 11) [NCBI Gene 2767] {aka FBH, FBH2, FHH2, GNA-11, HG1K, HHC2}, LINC00328 (long intergenic non-protein coding RNA 328) [NCBI Gene 51152] {aka NCRNA00328, NCRNA00328-1, NCRNA00328A}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}
- **Diseases:** benign conjunctival nevus (MESH:D003229), Iris (MESH:D007499), benign melanocytic lesion (MESH:D009508), anterior chamber angle melanoma (MESH:C535679), vision loss (MESH:D014786), pigmented lesions (MESH:D010859), conjunctival melanoma (MESH:D008545)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12145993/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12145993/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12145993/full.md

---
Source: https://tomesphere.com/paper/PMC12145993